VC Deals
LifeBond, an Israel-based developer of surgical sealants, has raised $27 million in Series D funding. Backers include Adams Street Partners, Sino Biopharmaceutical and return backers Pitango Venture Capital, Glenrock Israel and Zitelman Group
Practo, an Indian search portal that matches physicians with patients, has raised $90 million in Series C funding.Tencent led the round, and was joined by Google Capital, Yuri Milner, Sofina, Altimeter Capital and return backers Sequoia Capital and Matrix Partners. The company had raised a $30 million Series B round back in February
Cold Genesys Inc., a Santa Ana, Calif.-based oncolytic immunotherapy company, has raised $10 million in Series B funding. Ally Bridge Group and WI Harper Group co-led the round, and were joined by Whitesun Healthcare Ventures and Song Hong Fang
InfoBionic Inc., a Lowell, Mass.-based developer of patient monitoring solutions for chronic disease management, has raised $8 million in Series B-1 funding. Safeguard Scientifics led the round, and was joined by return backers like Excel Venture Management and Zaffre Investments
Avitide Inc., a Lebanon, N.H.-based developer of on-demand affinity purification solutions for the biopharma industry, has raised an undisclosed amount of Series C funding. NeoMed Management led the round, and was joined by return backers Polaris Partners, OrbiMed Advisors, SV Life Sciences and Borealis Ventures
JenaValve Technology Inc., an Irvine, Calif.-based maker of transcatheter aortic valve repair systems, has raised $26.5 million in Series C funding. RMM andValiance co-led the round, and were joined by Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management and VI Partners
Board Vitals, a 2.5-year-old, New York-based test preparation platform for the Medical Specialty Boards, has raised $1.1 million in Series A funding from Rock Creek Capital
Lemonade Lab, a three-year-old, Tokyo, Japan-based company that develops sensors for athletes, has raised $5.8 million in funding led by a Foxconn subsidiary called FIH Mobile that provides manufacturing services for mobile device makers. The company has now raised $10.3 million altogether
PE Deals
CCRM, a Colorado-based network of fertility treatment services providers, has raised an undisclosed amount of growth equity funding from TA Associates
New Heritage Capital has acquired PRN Ambulance, a provider of inter-facility medical transport services in the Los Angeles area. No financial terms were disclosed
IPO Deals
Mevion Medical Systems, a Littleton, Mass.-based provider of proton therapy systems, has raised $200 million in new equity funding. HOPU Investments and YuanMing Capital co-led the round, and were joined by return backers Caxton Alternative Management L.P., ProQuest Investments, Venrock and CHL Medical Partners. Mevion and its lead investors also will form a joint venture to make, sell and service proton therapy systems for the Chinese market. Financing terms for the JV are still being worked out, with new capital expected on top of the $200 million
Intec Pharma, an Israel-based developer of an oral drug delivery system for a Parkinson’s disease treatment, raised $30 million in its IPO. The pre-revenue company priced 5 million shares at $6 per share. It will trade on the Nasdaq under ticker symbol NTEC, and continue to trade in Tel Aviv under ticker symbol INTP. Maxim Group and Roth Capital served as underwriters
Zynerba Pharmaceuticals Inc., a Devon, Penn.-based developer of synthetic cannabinoid therapeutics formulated for transdermal delivery, raised $42 million in its IPO. The company priced 3 million shares at $14 per share (middle of $13-$15 range), for an initial market cap of around $128 million. It will trade on the NYSE under ticker symbol ZYNE, while Jefferies and Piper Jaffray served as lead underwriters
Aimmune Therapeutics, a Brisbane, Calif.-based developer of an oral immunotherapy to desensitize peanut allergies, raised $160 million in its IPO. The company priced 10 million shares at $16 per share (high end of $14-$16 range), for an initial market cap of around $651 million. It will trade on the Nasdaq under ticker symbol AIMT, with Bof A Merrill Lynch, Credit Suisse and Piper Jaffray serving as lead underwriters. Shareholders include Longitude Capital (23.16% pre-IPO stake), Foresite Capital (12.28%), Fidelity (8.57%), Food Allergy Research & Education (8.37%), Aisling Capital (7.14%), Adage Capital, RA Capital Management and Palo Alto Investors
Planet Fitness, a Newington, N.H.-based health club chain, raised $216 million in its IPO. The company priced 13.5 million shares at $16 per share (high end of $14-$16 range), for an initial market cap of around $564 million. It will trade on the NYSE under ticker symbol PLNT, while J.P. Morgan was listed as left lead underwriter. The company reports $37.3 million in net income on $279.8 million in revenue for 2014, compared to $25.8 million of net income on $211 million in revenue for 2013. Shareholders include TSG Consumer Partners
Practice Fusion may be prepping for an IPO. It just brought onboard Alan Black, CFO at the now publicly traded help-desk software company Zendesk, as its audit chair
Global Blood Therapeutics, a three-year-old, San Francisco-based company whose early-stage drug is designed to treat the serious blood condition sickle cell disease and that filed to go public last month, has revealed plans to sell six million shares at $16 to $18 per share. At the midpoint of that range, the offering would bring in $102 million. Currently, the company’s two biggest shareholders are Third Rock Ventures, which owns a 63 percent stake, andFidelity, which owns 13.2 percent
Other Deals
Genex Systems, a Wayne, Penn.-based provider of workers’ compensation clinical services, has acquiredComprehensive Industrial Disability Management Services Inc., a Westlake Village, Calif.-based provider of utilization review software and services to the workers’ compensation market
Cintas Corp. (Nasdaq: CTAS) has acquired ZEE Medical, an Irvine, Calif.-based provider of van-delivered first aid and safety services, from McKesson Corp.(NYSE: MCK) for approximately $130 million
Premier Inc. (Nasdaq: PINC) has agreed to acquireCECity Inc., a Homestead, Penn.-based provider of cloud-based healthcare improvement solutions, for $400 million
Shire PLC (Nasdaq: SHPG) has offered to acquire Deerfield, Ill.-based biotech company Baxalta (NYSE: BXLT) for $45.23 billion in stock, or $45.23 per share (36% premium over yesterday’s closing price). Baxalta (NYSE: BXLT) has rejected a $30.6 billion all-stock takeover offer from Shire PLC (Nasdaq: SHPG), saying that it “significantly undervalues” the company. The $45.23 per share offer represented a 36% premium over Monday’s closing price for Baxalta stock
Team Health Holdings (NYSE: TMH), a provider of provider of outsourced physician staffing solutions for U.S. hospitals, has agreed to acquire North Hollywood, Calif.-based IPC Healthcare (Nasdaq: IPCM), for $1.6 billion in cash
Adidas (DB: ADS) has acquired Runtastic, an Austrian maker of fitness tracking apps, for €220 million. Runtastic had raised an undisclosed amount of VC funding from Axel Springer Venture and i5invest Beratungs
IBM (NYSE: IBM) has agreed to acquire Merge Healthcare Inc. (Nasdaq: MRGE), a Chicago-based provider of medical imaging management solutions that will be merged into IBM’s Watson group. The deal is valued at around $1 billion in cash, or $7.13 per share (31.79% premium on Wednesday’s closing price)
Sources: Term Sheet, Financial Times, StrictlyVC, TechinAsia, CrunchBase, TechCrunch, Bloomberg
#healthtech #asia
